Opko Health Inc (OPK) concluded trading on Thursday at a closing price of $1.35, with 4.47 million shares of worth about $6.03 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -10.00% during that period and on May 01, 2025 the price saw a loss of about -2.17%. Currently the company’s common shares owned by public are about 671.55M shares, out of which, 303.35M shares are available for trading.
Stock saw a price change of -7.53% in past 5 days and over the past one month there was a price change of -18.67%. Year-to-date (YTD), OPK shares are showing a performance of -8.16% which increased to 8.87% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.15 but also hit the highest price of $2.04 during that period. The average intraday trading volume for Opko Health Inc shares is 5.08 million. The stock is currently trading -6.10% below its 20-day simple moving average (SMA20), while that difference is down -17.33% for SMA50 and it goes to -13.10% lower than SMA200.
Opko Health Inc (NASDAQ: OPK) currently have 671.55M outstanding shares and institutions hold larger chunk of about 31.49% of that.
The stock has a current market capitalization of $906.59M and its 3Y-monthly beta is at 1.42. It has posted earnings per share of -$0.09 in the same period. It has Quick Ratio of 3.13 while making debt-to-equity ratio of 0.37. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OPK, volatility over the week remained 5.17% while standing at 5.34% over the month.
Analysts are in expectations that Opko Health Inc (OPK) stock would likely to be making an EPS of -0.1 in the current quarter, while forecast for next quarter EPS is -0.09 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.1 which is -0.1 at the higher side of the target for the same. Stock’s fiscal year EPS is expected to drop by -273.21% while it is estimated to increase by 26.79% in next year. EPS is likely to shrink at an annualized rate of -15.52% for next 5-years, compared to annual growth of 32.04% made by the stock over the past 5-years.
Coverage by Barrington Research stated Opko Health Inc (OPK) stock as an Outperform in their note to investors on June 29, 2023, suggesting a price target of $2 for the stock. Stock get a Buy rating from Ladenburg Thalmann on June 21, 2021.
